Continuous Glucose Monitoring for Gestational Diabetes: Impact on Time-in-Range and Neonatal Outcomes

Abstract

Continuous glucose monitoring may enhance safety and precision in gestational diabetes care. In pragmatic clinics, CGM use increased maternal time-in-range and reduced undetected nocturnal hypoglycemia compared with capillary monitoring alone. Trends toward lower rates of neonatal hypoglycemia and large-for-gestational-age births were observed. Implementation requires tailored education on postprandial targets and integration with diet and insulin protocols.